Progress in the development of human parainfluenza virus vaccines

Functional Maturation of the Human Antibody Response to Rotavirus

(2014) N. L. Kallewaard et al.   JOURNAL OF IMMUNOLOGY

Viral Etiology of Severe Pneumonia Among Kenyan Infants and Children

(2010) James A. Berkley   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The route of priming influences the ability of respiratory virus–specific memory CD8+T cells to be activated by residual antigen

(2010) Shiki Takamura et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Respiratory Virus Pneumonia after Hematopoietic Cell Transplantation (HCT): Associations between Viral Load in Bronchoalveolar Lavage Samples, Viral RNA Detection in Serum Samples, and Clinical Outcomes of HCT

(2010) Angela P. Campbell et al.   JOURNAL OF INFECTIOUS DISEASES

The C Proteins of Human Parainfluenza Virus Type 1 Limit Double-Stranded RNA Accumulation That Would Otherwise Trigger Activation of MDA5 and Protein Kinase R

(2010) J. Boonyaratanakornkit et al.   JOURNAL OF VIROLOGY

Global, regional, and national causes of child mortality in 2008: a systematic analysis

(2010) Robert E Black et al.   LANCET

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys

(2010) Anne Schaap-Nutt et al.   VACCINE

Melanoma Differentiation-Associated Gene 5 (MDA5) Is Involved in the Innate Immune Response to Paramyxoviridae Infection In Vivo

(2010) Leonid Gitlin et al.   PLoS Pathogens

Control of an Outbreak of Human Parainfluenza Virus 3 in Hematopoietic Stem Cell Transplant Recipients

(2009) Richard T. Maziarz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study

(2009) A. Piralla et al.   HAEMATOLOGICA

Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of Hospitalization

(2009) Geoffrey A. Weinberg et al.   JOURNAL OF PEDIATRICS

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates

(2009) James P Watt et al.   LANCET

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

PHASE-I STUDY MEDI-534, OF A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS AND PARAINFLUENZA-3 VIRUS IN SEROPOSITIVE CHILDREN

(2009) Margarita Gomez et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Croup presentations to emergency departments in Alberta, Canada: A large population-based study

(2009) Rhonda J. Rosychuk et al.   PEDIATRIC PULMONOLOGY

Impact of a school-based influenza immunization program on disease burden: Comparison of two Tennessee counties

(2009) Katherine A. Poehling et al.   VACCINE

A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates

(2009) Emmalene J. Bartlett et al.   VACCINE

Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus

(2008) Joshua J. Shinoff et al.   JOURNAL OF INFECTIOUS DISEASES

The C Proteins of Human Parainfluenza Virus Type 1 (HPIV1) Control the Transcription of a Broad Array of Cellular Genes That Would Otherwise Respond to HPIV1 Infection

(2008) J. B. Boonyaratanakornkit et al.   JOURNAL OF VIROLOGY

Croup

(2008) Candice L Bjornson et al.   LANCET

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

(2008) Maria Florencia Delgado et al.   NATURE MEDICINE

Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults

(2008) Roderick S. Tang et al.   VACCINE